Suzuki, H. and Stanley, A.J. (2001) Current management and novel therapeutic strategies for refractory ascites and hepatorenal syndrome. QJM: An International Journal of Medicine, 94(6), pp. 293-300. (doi: 10.1093/qjmed/94.6.293) (PMID:11391027)
Full text not currently available from Enlighten.
Abstract
The circulatory disturbances seen in advanced cirrhosis lead to the development of ascites, which can become refractory to diet and medical therapy. These abnormalities may progress and cause a functional renal failure known as the hepatorenal syndrome. Management of refractory ascites and hepatorenal syndrome is a therapeutic challenge, and if appropriate, liver transplantation remains the best treatment. New therapeutic options have recently appeared, including the transjugular intrahepatic portosystemic shunt and selective splanchnic vasoconstrictor agents, which may improve renal function and act as a bridge to transplantation.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Stanley, Dr Adrian |
| Authors: | Suzuki, H., and Stanley, A.J. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing |
| Journal Name: | QJM: An International Journal of Medicine |
| Publisher: | Oxford University Press |
| ISSN: | 1460-2725 |
| ISSN (Online): | 1460-2393 |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details